Soc. Generale Knock-Out OMV 21.03.../ DE000SJ09DA3 /
15/11/2024 17:37:24 | Chg.+0.400 | Bid17:54:38 | Demandez à17:54:38 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
8.600EUR | +4.88% | - Bid taille: - |
- Ask la taille: - |
OMV AG | - EUR | 21/03/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page